Hezkue for Erectile Dysfunction

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: Aspargo Labs, Inc

No Placebo Group

Trial Summary

What is the purpose of this trial?The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects

Eligibility Criteria

This trial is for healthy adult men who are interested in understanding how food affects the absorption and effectiveness of a new erectile dysfunction medication called Hezkue (sildenafil).

Inclusion Criteria

Participant must be informed of the nature of the study and voluntarily agree to participate by signing an informed consent form prior to any study-specific procedures

Participants must agree to practice an acceptable method of contraception as outlined in the protocol

My kidneys are functioning well, with a creatinine clearance over 80 mL/min.

+3 more

Exclusion Criteria

Unwillingness or inability to follow the procedures specified by the protocol

Participant received any investigational drug/product within 30 days prior to the first dose

Presence of any clinically significant results from laboratory tests, vital signs assessments, and electrocardiograms

+28 more

Participant Groups

The study is testing whether eating before taking Hezkue (100 mg) changes its effects compared to taking it without food. This phase 1 trial will compare the two scenarios in participants.

2Treatment groups

Experimental Treatment

Group I: Arm 2- Fed vs Fasted ConditionsExperimental Treatment1 Intervention

Participants receive 100mg of ASP-001.1 first under fed conditions and under fasted conditions after

Group II: Arm 1 - Fasted vs Fed ConditionsExperimental Treatment1 Intervention

Participants receive 100mg of ASP-001.1 first under fasted conditions and under fed conditions after